Pleger ST - Search Results

1

S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.

Brinks H, Rohde D, Voelkers M, Qiu G, Pleger ST, Herzog N, Rabinowitz J, Ruhparwar A, Silvestry S, Lerchenmüller C, Mather PJ, Eckhart AD, Katus HA, Carrel T, Koch WJ, Most P. Brinks H, et al. Among authors: pleger st. J Am Coll Cardiol. 2011 Aug 23;58(9):966-73. doi: 10.1016/j.jacc.2011.03.054. J Am Coll Cardiol. 2011. PMID: 21851887 Free PMC article.

2

S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance.

Most P, Remppis A, Pleger ST, Katus HA, Koch WJ. Most P, et al. Among authors: pleger st. Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R568-77. doi: 10.1152/ajpregu.00075.2007. Epub 2007 Apr 25. Am J Physiol Regul Integr Comp Physiol. 2007. PMID: 17459908 Free article. Review.

3

S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy.

Kraus C, Rohde D, Weidenhammer C, Qiu G, Pleger ST, Voelkers M, Boerries M, Remppis A, Katus HA, Most P. Kraus C, et al. Among authors: pleger st. J Mol Cell Cardiol. 2009 Oct;47(4):445-55. doi: 10.1016/j.yjmcc.2009.06.003. Epub 2009 Jun 16. J Mol Cell Cardiol. 2009. PMID: 19538970 Free PMC article. Review.

4

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.

Most P, Pleger ST, Völkers M, Heidt B, Boerries M, Weichenhan D, Löffler E, Janssen PM, Eckhart AD, Martini J, Williams ML, Katus HA, Remppis A, Koch WJ. Most P, et al. Among authors: pleger st. J Clin Invest. 2004 Dec;114(11):1550-63. doi: 10.1172/JCI21454. J Clin Invest. 2004. PMID: 15578088 Free PMC article.

5

S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.

Pleger ST, Remppis A, Heidt B, Völkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Müller OJ, Eckhart AD, Katus HA, Koch WJ, Most P. Pleger ST, et al. Mol Ther. 2005 Dec;12(6):1120-9. doi: 10.1016/j.ymthe.2005.08.002. Epub 2005 Sep 15. Mol Ther. 2005. PMID: 16168714 Free article.

6

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue.

Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W, Gao E, Dasgupta A, Rengo G, Remppis A, Katus HA, Eckhart AD, Rabinowitz JE, Koch WJ. Pleger ST, et al. Among authors: pleger w. Circulation. 2007 May 15;115(19):2506-15. doi: 10.1161/CIRCULATIONAHA.106.671701. Epub 2007 Apr 30. Circulation. 2007. PMID: 17470693

7

Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.

Pleger ST, Boucher M, Most P, Koch WJ. Pleger ST, et al. J Card Fail. 2007 Jun;13(5):401-14. doi: 10.1016/j.cardfail.2007.01.003. J Card Fail. 2007. PMID: 17602988 Review.

8

Recent findings into the potential of gene therapy to reverse heart failure.

Pleger ST, Most P, Koch WJ. Pleger ST, et al. Expert Opin Biol Ther. 2007 Dec;7(12):1781-4. doi: 10.1517/14712598.7.12.1781. Expert Opin Biol Ther. 2007. PMID: 18034643

9

Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.

Pleger ST, Shan C, Ksienzyk J, Bekeredjian R, Boekstegers P, Hinkel R, Schinkel S, Leuchs B, Ludwig J, Qiu G, Weber C, Raake P, Koch WJ, Katus HA, Müller OJ, Most P. Pleger ST, et al. Sci Transl Med. 2011 Jul 20;3(92):92ra64. doi: 10.1126/scitranslmed.3002097. Sci Transl Med. 2011. PMID: 21775667 Free PMC article.

10

S100A1 gene therapy in small and large animals.

Most P, Raake P, Weber C, Katus HA, Pleger ST. Most P, et al. Among authors: pleger st. Methods Mol Biol. 2013;963:407-20. doi: 10.1007/978-1-62703-230-8_25. Methods Mol Biol. 2013. PMID: 23296625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page